Brainstorm Cell Therapeutics BCLI
OTC BCLI
$0.99 +0.07 (+7.61%)
At close: Nov 10, 2026 · 4:00 PM EST

Brainstorm Cell Therapeutics (BCLI) Short-Term Debt issuances (2025 - 2026)

Updated

Brainstorm Cell Therapeutics (BCLI) posted Short-Term Debt issuances of -$125,000 for Q2 2026, compared with -$1.1 million a year earlier.

Analysis

Brainstorm Cell Therapeutics (BCLI) Short-Term Debt issuances (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Short-Term Debt issuances at Brainstorm Cell Therapeutics was $936,000; for FY2025, it was $582,000.

  • Quarterly Short-Term Debt issuances has run from a low of -$1.1 million in Q2 2025 to a high of $900,000 in Q1 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.28 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Brainstorm Cell Therapeutics 10.92 Mn 10.85 Mn - -125,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -125,000.00
Mar 31, 2026 280,000.00
Dec 31, 2025 781,000.00
Jun 30, 2025 -1.10 Mn
Mar 31, 2025 900,000.00
API Access

Brainstorm Cell Therapeutics Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=BCLI&period=max&api_key=YOUR_API_KEY